Objectives: Because End of life (EOL) is becoming an increasingly long life stage, this paper aims to describe the delineation of EOL by reviewing studies which examine (a) terminal decline (TD), the timing of change in slope of decline in specific abilities; and (b) trajectories of decline in areas such as function, health care expenditures, and well-being according to cause of death. Methods: Studies were identified through Google Scholar, PsycNET, and PubMed. Results: TD was identified in diverse domains. Most findings focused on decline of cognitive abilities, and they reported this to occur 3-7 years prior to death. TD in wellbeing was found to begin 3-5 years prior to death. Trajectories by cause of death generally examined sudden death, terminal illness, organ failure, and frailty, and findings described differences in costs, function, and wellbeing, though examining a shorter predeath period than the TD literature. Discussion: Further research is needed to combine methods of investigation in order to assist the health care system in personalizing services to the trajectories of decline, and in enabling caregivers to prepare for the EOL experience. End of Life (EOL) has become an often-prolonged distinct life stage. Questions concerning how much time one has left or the anticipated quality of life have important implications for evaluating and prioritizing interventions. Understanding the type and timing of decline before death is critical on both individual and policy levels. In terms of the individual level, it can provide an outlook of what to prepare for in one's own life and in that of one's cohort, even though variability included in current data may not lend itself to effective individualized preparation. On a policy level, such investigation is informative for setting priorities (e.g., when is wellbeing compromised), as well as developing prevention and intervention programs.
End of Life (EOL) has become an often-prolonged distinct life stage. Questions concerning how much time one has left or the anticipated quality of life have important implications for evaluating and prioritizing interventions. Understanding the type and timing of decline before death is critical on both individual and policy levels. In terms of the individual level, it can provide an outlook of what to prepare for in one's own life and in that of one's cohort, even though variability included in current data may not lend itself to effective individualized preparation. On a policy level, such investigation is informative for setting priorities (e.g., when is wellbeing compromised), as well as developing prevention and intervention programs.
Two general approaches have been used in EOL research, one describing Terminal Decline (TD) and the other describing EOL trajectories by main causes of death. TD refers to the process of mortality-related deterioration as manifested in two stages: (a) a preterminal phase of relative stability or minor decline and (b) a terminal phase that, while potentially extending over years, is characterized by a steeper decline that ends in death (Gerstorf et al., 2008) . Researchers studying this phenomenon usually use longitudinal studies with multiple repeated assessments of a characteristic or function and perform retrospective analyses on the data of those who died. Researchers calculate TD by analyzing the patterns of rate of change of performance in different domains (e.g., cognitive, subjective well-being) as a function of distance from death (Gerstorf et al., 2008; Wilson, Beck, Bienias, & Bennett, 2007) . Usually, the change is plotted for each participant individually (Wilson et al., 2012) , and then group-based estimates of either the slope of TD or the slopes of both preterminal and terminal stages are calculated. The time of conversion from preterminal to TD, as measured in distance from death, is also calculated. This procedure often presents two figures of linear decline with different slopes, but it can also be presented as one curvilinear figure.
The alternative approach identifies trajectories of decline according to cause of death and describes these trajectories by duration and shape in terms of function or expenditures (Lunney, Lynn, Foley, Lipson, & Guralnik, 2003; Lunney, Lynn, & Hogan, 2002) . Using clinical profiles, Lunney et al. (2002) identified four groups representing EOL trajectories differing in duration and shape (Figure 1 ): sudden death, terminal illness, organ failure, and frailty. The Sudden death group consisted of people who progressed from normal function to death with little forewarning, often with little interaction with the health care system. The Terminally-ill group consisted of people who died after a distinct phase of terminal illness. These persons may function relatively well for a long period of time and then experience a rapid decline until death (e.g., in cancer). The Organ failure group primarily included people with a serious and eventually fatal organ system failure, such as congestive heart failure or chronic obstructive pulmonary disease. They typically exhibit a relatively gradual decline with frequent episodic acute exacerbations of their illness. Whereas every episode can potentially result in death, most patients experience a few episodes. Lastly, the Frailty group included people who suffer from Alzheimer's disease, stroke, Parkinson's, and other types of dementia and long-term diseases which show a slow and gradual decline.
To date, the literature on EOL in these two areas of investigation has not been fully summarized nor considered conjointly. This review aims to describe the research available from these two perspectives and to consider their implications for future study of end of life. The purpose of describing the available research is to highlight the commonalities and differences in the two approaches in clarifying EOL processes, and thus to encourage deliberation for improving this type of study. Gaining a better understanding of the patterns of decline during the EOL period will aid in optimizing care and better preparing patients and family members. It is also likely to inform planning, as knowing when a cohort will start declining in a certain function will provide guidance for prevention, intervention, and support services to mitigate or address the anticipated losses.
Methods

Search Strategy
This review includes published English language articles on TD, trajectories of function, and expenditures at EOL. Electronic searches were conducted on Google Scholar, PsycNET, and PubMed, for 2003-2017 . The search for TD publications included the phrases: "TD" or "Terminal drop", combined with "end of life" or "mortality", whereas the search for trajectories of EOL included the phrases "trajectory" or "trajectories" and "end of life." When the search yielded more than several hundred results, the search was redone, limiting results to articles that had these terms in the title. Additional articles were added based on reviewing the references of the articles found in the search.
Inclusion Criteria
Inclusion criteria were the following: (a) a domain-specific TD was described in general or in relation to cause of death, (b) trajectories of decline in one or more types of diseases (causing death) were assessed, or (c) causes of death were compared for changes in costs, expenditures, or health services consumption in the last years of life. Articles that did not present original research or that were unrelated to the subject matter were considered "irrelevant." Titles and abstracts of the remaining articles were inspected for relevancy, and those the team agreed on were read and included.
The principal summary measure used by articles on TD was the point in time before death when different functional domains showed accelerated decline. This pertained to cognitive, emotional, and physical function. The principal summary measures of trajectories by cause of death were: prevalence (of trajectory); expenditures and health services utilization; and rate of decline in function, health, cognition, and quality of life. We examine several explanations for differences in results across studies.
Articles Included
Based on the search, we found 50 articles about TD and trajectories of EOL that were used in our review. The flowchart of our search is presented in Figure 2 .
Results
TD in Diverse Domains
TD was investigated in four domains: cognitive, emotional well-being and life satisfaction, weight-loss, and physical function. Articles dealing with TD onsets (in years prior to death) in these domains are summarized in Supplementary  Table 1 . The cognitive domain is measured with tools such as memory tests, perceptual speed tests, and reading and numbering tasks (Wilson et al., 2013) ; well-being is assessed by questionnaires measuring emotions, mental health, life satisfaction, and quality of life (Gerstorf et al., 2014; Schilling, Wahl, & Wiegering, 2013; Wilson et al., 2013) ; and weightloss and physical function through physical measurements and motor tests (Alley et al., 2010; Wilson et al., 2012) .
The concept of onset of TD can be operationalized through the use of single or multiphase models. Gerstorf et al. (2016) , for example, consider both single-phase and multiphase models. Single-phase models describe long-term predeath trajectories of stability and/or change, while multiphase models focus on the transition to a stage of late-life decline (Gerstorf et al., 2016) . Multiphase models typically describe a process that starts with a slow rate of change, and then continues with a more pronounced acceleration towards death (Cadar et al., 2016; Wilson et al., 2007) . In other models, individuals are aligned according to chronological age as well as time-to-death (Sliwinski et al., 2006; Thorvaldsson et al., 2008) .
Cognitive decline
The most frequently investigated domain within the framework of TD is that of cognitive decline, with 20 articles dealing with some aspect of this domain. Overall, declines in different cognitive domains were found to be significant predictors of mortality (Lavery, Dodge, Snitz, & Ganguli, 2009; Thorvaldsson et al., 2008) . The articles examined global cognitive decline as well as declines in specific cognitive functions, such as perceptual speed, episodic memory, semantic memory, or spatial ability, and found different time-points of change in rate of decline among these areas, varying from less than 3 years to over 14 years before death (see Supplementary Table 1 ). This variation was not only related to the specific function examined, but also to the specific measure used to assess it (Supplementary Table 1 ) (Batterham, Mackinnon, & Christensen, 2011; Gerstorf, Ram, Hoppmann, Willis, & Schaie, 2011; Wilson, Beckett, Bienias, Evans, & Bennett, 2003) , and to background characteristics, such as education (Batterham et al., 2011; Terrera, Minett, Brayne, & Matthews, 2014) . For example, using a specific combination of tests from different cognitive domains to measure cognitive decline (Wilson et al., 2007; Wilson et al., 2003; Wilson, Leurgans, Boyle, Schneider, & Bennett, 2010) , studies found the onset of TD to be between 3.5-4.5 years before death, whereas studies using the Mini-Mental State Examination (MMSE) reported onset of change in rate of decline as 6.2, 7.1, and 7.7 years before death (Batterham et al., 2011; Muniz-Terrera, van den Hout, Piccinin, Matthews, and Hofer, 2013) . This difference may be due to the MMSE being a more general screening tool than other measures. It may also be due to the specific populations tested. The research on whether education affects these processes by providing cognitive reserve, thereby either decreasing the rate of decline in cognitive performance or resulting in a higher predeath cognitive function, is as yet inconclusive. However, the preponderance of the evidence suggests that education does not decrease the rate of TD (Cadar et al., 2016; Terrera et al., 2014; Muniz-Terrera et al., 2013) , and Gerstorf et al. (2011) and Hülür, Infurna, Ram, & Gerstorf (2013) found steeper TDs in cognitive abilities in more recent cohorts, despite slower decline trajectories prior to the TD. Decline in some domains is also dependent on dementia (Lavery et al., 2009) , in that the proportion of persons with dementia in the sample may affect the findings. Specifically, those with dementia display significant global cognitive decline until death, whereas those without dementia manifest TD in specific cognitive tests, such as word fluency (Laukka, MacDonald, & Bäckman, 2008) . Finally, it remains unclear whether the decline is best represented as a linear or nonlinear function (Sliwinski et al., 2006; Wilson et al., 2007) .
Emotional well-being and life satisfaction decline
We found eight articles that dealt with decline in emotional well-being and life satisfaction (Supplementary Table 1 ). In these studies, outcome was assessed using various questionnaires, including the Philadelphia Geriatric Center Morale Scale (Gerstorf et al., 2008) , the Center for Epidemiologic Studies Depression Scale Revised (Gerstorf et al., 2010) , and the Short-Form Health Survey 36 (Burns, Mitchell, Shaw, & Anstey, 2014) . Decline in subjective well-being, life satisfaction, and overall health was found to be more closely related to distance from death than to age (Gerstorf et al., 2008; Palgi et al., 2010) . Well-being was found to change from stability throughout adulthood to a decline around 3-5 years before death. The change point for positive affect was found to be earlier than that for negative affect, with the former starting to decrease 5.6 years prior to death and the latter increasing at 3.7 years prior to death (Vogel, Schilling, Wahl, Beekman, & Penninx, 2013) . The relationship of change of negative affect with time-to-death was stronger than that for change of positive affect, and acceleration was faster Vogel et al., 2013) . Feeling in personal control of one's life was associated with a less steep late-life decline in well-being and with a later onset of TD (Gerstorf et al., 2014) .
Physical function and weight
Three articles dealt with physical function, and one of these also investigated the onset of weight decline (Alley et al., 2010) . Using at least seven annual clinical assessments of motor function (evaluated by 11 motor tests), Wilson et al. (2012) found that global motor function declined a mean of 0.024-unit per year until an average of 2.46 years prior to death, when rate of decline increased nearly fivefold; analyzing different motor tests separately yielded the same results. The onset of motor TD was highly correlated with the onset of general cognitive TD, though rates of cognitive and motor declines were not themselves strongly correlated (Wilson et al., 2012) . Higher baseline quality of life was associated with a less steep TD in physical functioning (Shrira et al., 2015) .
Unintentional weight loss in old age can be a marker of health deterioration and approaching death (Alley et al., 2010) . Based on an average of 19 years of observation, a model with 3 distinct periods of weight change (weight stability/gain, mild weight loss, and accelerated weight loss preceding death) provided the best fit for all age-at-death groups. Approximately 9 years before death, the rate of weight loss initially increased, with an accelerated weight loss differing by disease.
Trajectories of End of Life
We found 17 papers that specifically addressed the trajectories at end of life in relation to cause of death. Most research comparing trajectories focused on the last year, or even last months, of life (Murtagh, Addington-Hall, & Higginson, 2011) , although TD as described above usually starts earlier. Key dimensions distinguishing between the main trajectories are summarized in Table 1 and described below. Some studies examined trajectories in different ways; one such study compared characteristics of people in the following different groups: high-functioning, no decline; highfunctioning, gradual decline; and low-functioning, steep decline (Cosco, Stephan, Muniz, & Brayne, 2016) .
Sudden Death
Sudden death occurs when a person progresses quickly from normal functioning to death (Lunney et al., 2002) .
Sudden death accounted for 7% of deaths in Lunney et al.'s study (2002 ), 7.1% in Fassbender, Fainsinger, Carson, & Finegan (2009 , and 15% of all deaths in Lunney et al. (2003) . Specific causes of death in this group vary more than in other groups; they include sudden cardiac failure, aneurysms, toxins, and accidents. In the study by Lunney et al. (2002) , only 1% of this group died as hospital inpatients. Persons in this group were relatively younger (mean age = 73), more likely to be men (61%), and included more minorities (especially under the age of 75) than any of the other groups (Lunney et al., 2002) .
Expenditures and use of health care services According to Fassbender et al. (2009) , cost for sudden death was the lowest of the four groups, with physicians and ambulatory care constituting the primary costs-75% of all sudden deaths received ambulatory care. The rate of expenditure growth in the 2 years prior to death remains low until about 3-1 months prior to death, when it increases by a factor of 3.6.
Decline
People in this group were substantially more independent than people in the other three groups and did not show a decline in general function (operationalized as activities of daily living) as death approached (Lunney et al., 2003) .
Health and quality of life decline and cognitive decline Based on the above findings, it seems that, in comparison to the other groups, those who experience sudden death are less likely to experience significant health and quality of life decline or cognitive decline.
Terminal Illness
Deaths from terminal illness, such as cancer, constitute about 20%-30% of all deaths (Fassbender et al., 2009; Lunney et al., 2002) . People in this group tend to die younger than those in the two subsequent groups, with 40% dying under the age of 75 (Lunney et al., 2002) .
Expenditures and use of health care services
Rate of growth, but not absolute number, of expenditures in the last 18 months of life is higher than in other groups. According to a Canadian study, costs nearly triple for this group during the last six months of life (Fassbender et al., 2009) , with the primary cost in the last year being inpatient care (Fassbender et al., 2009) . Homecare use in the last year of life is highest for the terminal illness group (Fassbender et al., 2009) , as is physician services (Lunney et al., 2002) .
Decline
Most studies show a general drastic decline for patients in this group in the last 3 months prior to death (Costantini, Beccaro, & Higginson, 2008; Giesinger et al., 2011; Lunney et al., 2003) . Decline in function in the last year of life was greatest for terminally-ill patients (Chen, Chan, Kiely, Morris, & Mitchell, 2007; Lunney et al., 2003) : 94% were free from functional disability a year prior to death, which declined to 63% at 12 weeks prior, and to 49% about 6 weeks preceding death. Their terminal phase is often clearer than that of other groups (Murray et al., 2007) .
Health and quality of life decline
Fatigue and quality of life worsen in the last 3 months of life, at least in the case of cancer patients (Giesinger et al., 2011) . Patients tend to have symptoms that are initially vague and are only diagnosed later. In cancer, side effects of treatment make people feel more ill than they did before treatment (Murray et al., 2007) . Weight loss for cancer patients was found to accelerate significantly around 3 years before death (Alley et al., 2010) . Cancer patients also experience increases in functional dependence, anxiety, and depressive symptoms, and decreases in perceived social support in the last few months before death (Tang et al., 2014) . In the case of lung cancer patients and cardiac failure patients, social trajectories mirrored physical decline, while psychological and spiritual well-being decreased together at four key transitions (diagnosis, discharge after treatment, disease progression, and the terminal stage), swinging from hope to despair (Murray et al., 2007) . Social lives start to disintegrate because of others' fears, and because treatment sets aside social plans. Thus, loneliness is common. Towards the terminal phase, the social world shrinks to family and then to self (Murray et al., 2007) .
Cognitive decline
Decline in most cognitive abilities does not typically differ with cause of death (Lavery et al., 2009) , especially when persons with dementia are excluded at baseline (Small, Fratiglioni, von Strauss, & Bäckman, 2003) , and it commonly predicts mortality across diverse types of diseases (Anstey, Mack, & von Sanden, 2006) . Some studies (Costantini et al., 2008; Giesinger et al., 2011) reported that, for cancer patients, cognitive functioning declined gradually 12-3 months prior to death but declined sharply in the last 3 months of life, conjointly with declines in other domains.
Organ Failure
This group constitutes 16%-30.5% of deaths (Fassbender et al., 2009; Lunney et al., 2003; Lunney et al., 2002; Wilson et al., 2012) . Average age of death in this group is higher than in the terminally ill group and lower than in the frailty group, with over 40% dying between the ages of 75-84 (Lunney et al., 2002) .
Expenditures and use of health care services
Average Medicare expenditures are the highest for the organ failure group (Fassbender et al., 2009; Lunney et al., 2002) , with costs increasing in the last year. The primary cost in the last year is for skilled nursing facilities (Fassbender et al., 2009; Lunney et al., 2002) . About 50% of the patients use homecare (compared to 77% of terminally-ill patients and 42% of frailty patients) (Fassbender et al., 2009) . Two years before death, expenditures for this group are five times higher than for those of the sudden death group and twice as much as for the terminally-ill group. During the succeeding months, expenditures grow more gradually than those of the terminally-ill, but faster than previously; 6-4 months before death, expenditures markedly rise, tripling in the last 3-1 months preceding death (Fassbender et al., 2009) . Nearly all decedents in this group are hospitalized during the last year of their life (Lunney et al., 2002) .
Decline
As in the terminally-ill group, there is a drastic decline in the last 3 months of life (Lunney et al., 2003) . Patients in this group experience a fluctuating pattern of decline, with substantially poorer function during the last 3 months (Lunney et al., 2003) , though the pattern for renal failure is more similar to that for the terminally-ill (Murtagh et al., 2011) . Rate of functional decline in the last year of life in those with organ failure is not as high as that of the terminally-ill, but it is higher than in the frailty group, though absolute functioning remains higher toward the end than in frailty (Chen et al., 2007) .
Health and quality of life decline
Organ failure patients have a relatively chronic trajectory with episodes of acute deterioration that often necessitate emergency admission. Overall, there is a progressive decline with an unpredictable terminal phase (Murray et al., 2007) . With respect to weight loss, Alley et al. (2010) found that the best fitting inflection point increased with age from 5 years prior to death for persons aged 60-69 years to 9-10 years for those aged 80 or older.
Cognitive decline
In their review of the relationship between cognitive function and mortality among persons with coronary heart disease, Anstey et al. (2006) conclude that cognitive function is a predictor of mortality in this population, but the results are less consistent than those for persons with cancer or stroke and are based on a small number of studies.
Frailty
People meeting criteria for frailty constitute 20%-47% of all deaths (Fassbender et al., 2009; Lunney et al., 2003) . This is the oldest age group, with 66% dying at age of 80 and above (Lunney et al., 2002) .
Expenditures and use of health care services
Average Medicare use and rate of expenditure growth in the last year is lower for this group than it is for the terminallyill and organ failure groups (Fassbender et al., 2009; Lunney et al., 2002) , but variability in costs is high, with patients suffering from stroke, delirium, and arthritis having higher costs than those with dementia (Kelley et al., 2011; Lunney et al., 2002) . Frailty leads all other causes of death in nursing homes and long-term care (Fassbender et al., 2009 ).
Decline
Unlike other groups, decline in the frailty group is very gradual (Lloyd, Kendall, Starr, & Murray, 2016) . Steady increases in the rates of functional dependency were evident at least 1 year before death, rather than a sudden increase shortly before death (Covinsky, Eng, Lui, Sands, & Yaffe, 2003) . Despite the fact that the decline for this group is very gradual, this is still considered TD, since it is an increased rate of decline in the years preceding death. The frailty group had the lowest rate of functional decline in the last year of life. However, their baseline starting (1 year before death) and end points were the lowest (Chen et al., 2007) , and they exhibited more dependence in activities of daily living than any other group (Lunney et al., 2003) .
Health and quality of life decline
Due to the gradual and slow progression of decline, this group is characterized by high comorbidity, which results in lower quality of life for longer periods of time than found in the other groups. This drawn out and lengthy period of end of life presents an obstacle to receiving palliative care benefits. Currently, in the United States, patients under Medicare qualify for EOL palliative care, or hospice, if their prognosis of survival is 6 months or less and they are willing to relinquish curative treatments and services (Kelley & Morrison, 2015) . This lack of adequate palliative care benefits can lead to discomfort and poor quality of life for patients, as well as financial and emotional distress for family members (Covinsky et al., 2003) . People in the frailty group are also commonly disabled in the last year of life and demonstrate substantial functional decline in the last 3 months (Lunney et al., 2003) .
Cognitive decline
The studies in our review did not mention the decline pattern of cognitive function for the frailty group, although it has been noted that having cognitive impairment at the start of TD in this group is associated with higher rates of functional impairment at end of life (Chen et al., 2007; Covinsky et al., 2003) .
Discussion
This review combined two lines of research on EOL, focusing on how TD manifests in different domains and how cause of death influences changes during EOL. TD often describes a gradual initial stage, which changes to an accelerated TD associated with time to death. While the findings reviewed support the robustness of the concept of TD, more research is needed in order to understand the variability and individual differences in onset, rate, and magnitude of TD. The results suggest some variability when the same test is used in a different study by a different author, but the variability is greater when different tests and different cognitive domains are examined. Variability has also been accounted for by the presence of dementia or preclinical dementia (for cognitive function), by sex, age, and cohort. This review also revealed differences in decline at EOL between different causes of death, as demonstrated in dissimilar trajectories, both in costs and in courses of decline in function and well-being. Yet, the literature investigating TD according to cause of death is sparse. Models of TD generally describe a transition to the terminal phase that occurs a few years prior to death, but research on EOL trajectories has tended to focus on the last year of life. Indeed, different methodologies and different types of data are used to study the two phenomena. Studies investigating the onset and rate of TD have been concerned with various skills and abilities or psychological states generally measured in longitudinal studies using standardized tests. After a number of years of data collection, the test scores of those who died are examined for TD. In contrast, EOL trajectories are more often based on interviews or on financial data. Such studies often use the diagnosis of the disease as the starting point and investigate the decline prospectively. A better understanding may be obtained by integrating methodologies, thereby investigating the effects of cause of death over longer time-periods and including medical, functional, mental health, and financial data together in research. For example, the change point in decline in various cognitive function domains likely varies by cause of death, as does the change point in other domains, such as weight or wellbeing. These should be explored as a way to clarify population level findings, as well as to explore the relationships between change points in different domains and the potential impact of change in one domain over another.
Areas of Future Research
The results of this review enhance the understanding of the concept of EOL as a stage of life, distinct from aging or other life stages. This stage can start several years prior to death, though the timing of its onset varies among individuals by function, domain, and disease. The onset of EOL, operationalized as the change point that signals the start of TD, requires further investigation, including exploring differences between domains and symptoms, such as fatigue, and their relationship to cause of death.
In considering these two lines of investigation, the exploration of TD versus trajectories of death-causing disease, multiple basic research questions arise, such as the following:
• Is TD a universal phenomenon or does it depend on the cause of death, medical disease or background characteristics? What is the impact of comorbidities in affecting TD, and can we discern the most critical elements, for example, specific disease processes, cognitive decline, or global multidisease burden? Is it possible to discern the impact of early functioning versus lifestyle versus disease processes/organ failures on TD? What is Such investigation needs to include very large sample sizes to examine TD within subgroups related to disease or to background characteristics. This knowledge will improve understanding of the underlying processes of TD, providing a more informed approach to EOL progression. For example, the onset of TD in various areas of cognition is likely associated with different types of diseases, including, but not limited to, the different types of dementia. Research would, thus, examine the timing of cognitive impairment among different disease trajectories, the differences in trajectories of decline based on type of dementia, and comparisons of these different trajectories based on background variables. The high variability in terms of the point of change for different cognitive functions highlights the need for further research about the relationships among the different domains in the context of TD. It also points to the changing focus of this research. Whereas early studies focused on a population level estimate of rate of TD and the onset of this rate, more recent research highlights the impact of disease and personal characteristics, which until now was mostly confined to dementia, sex, age, and cohort as factors affecting both parameters: onset and rate of decline. This dictates using much larger samples, which can provide specific findings regarding these parameters for different subpopulations. Such studies are necessary to differentiate between the impact of sample characteristics, the impact of the specific assessment used, and other study-specific biases on the determination of those parameters.
Research should also expand to other skills, abilities, and mental states that change at EOL. The literature on TD through the years has focused mainly on cognitive decline, with relatively few papers tapping other domains; Supplementary Table 1 demonstrates the range of constructs used to conceptualize and measure TD.
Future research needs to investigate the implications of the findings on TD, such as examining when to begin providing palliative care for different types of patients. By gaining more knowledge on the different trajectories of EOL in different diseases and by delineating each in terms of the order and rate of decline, and in turn, associated costs, the medical system will be able to better tailor both active and palliative health care to each type of disease. This could also assist with advocacy for better access to palliative care (Chen et al., 2007) , Moreover, this knowledge may enable researchers and caregivers to better pinpoint the beginning of EOL. This information would ultimately enhance the ability for health care professionals to target the timing and methods of prevention, intervention, and support programs. It would also help patients and families to better plan and prepare for the period preceding death and also recognize the impending death when it arrives.
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Supplementary data is available at The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences online.
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